Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol

    • Product Name (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol
    • Alias DTT(2S,3S)-protected
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    172078

    Chemical Name (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol
    Cas Number 112022-70-9
    Molecular Formula C23H28O8S2
    Molecular Weight 496.59
    Appearance White to off-white solid
    Melting Point 139-140°C
    Solubility Soluble in common organic solvents such as dichloromethane and chloroform
    Optical Rotation [α]20D -10° to -14° (c=1, CHCl3)
    Purity Typically ≥98%
    Storage Temperature 2-8°C, protected from light and moisture
    Synonyms (-)-DITHP, (-)-Di-O-Tosyl Isopropylidenethreitol
    Usage Chiral building block and reagent in organic synthesis

    As an accredited (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical is packaged in a 25g amber glass bottle with a screw cap, labeled with product details and safety information.
    Shipping This chemical, `(-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol`, is shipped in secure, sealed containers to prevent contamination and degradation. It is packed with appropriate labeling and documentation, handled in accordance with relevant chemical safety regulations, and transported via reliable couriers to ensure safe and timely delivery to the specified destination.
    Storage (-)-1,4-Di-O-Tosyl-2,3-O-isopropylidenethreitol should be stored in a tightly sealed container, protected from moisture and light, at a cool temperature (2–8°C, refrigerator). Store in a well-ventilated, dry area away from incompatible substances such as strong oxidizing agents and acids. Avoid prolonged exposure to air. Always follow local safety regulations when handling and storing chemical substances.
    Application of (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol

    Applications of (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol in Industrial Manufacturing

    As an original manufacturer, we supply (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol with strict quality control for advanced sectors. The following application scenarios represent verified, compliant uses addressing today's demands in pharmaceutical synthesis, fine chemical production, and specialty intermediates manufacturing.

    1. Chiral Auxiliary in Asymmetric Synthesis for Active Pharmaceutical Ingredients (APIs)

    Professional pharmaceutical processors use this raw material as a chiral auxiliary to induce high enantioselectivity in the synthesis of drug molecules with complex stereochemistry. It plays a direct role in multi-step processes for antidiabetic, antiviral, and cardiovascular APIs where absolute stereocontrol is crucial during carbon–carbon bond formation and ring-closing reactions. Plant QC departments monitor trace impurities and recover auxiliaries post-reaction, complying with strict global regulations for pharmaceutical intermediates.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • U.S. FDA 21 CFR Part 211 (cGMP for finished pharmaceuticals)
    • European Pharmacopoeia (Ph. Eur.) General Chapter 2038
    • USP-NF requirements for chiral intermediates

    Typical usage ratio

    • 20–40 mol% relative to prochiral substrate; adjusted based on target reaction and catalyst efficiency; recovery rate preferable above 80% for subsequent cycles

    Downstream process integration

    • Introduced during the key stereoselective step, often at cold reaction temperatures and in anhydrous conditions
    • Separated post-reaction by extraction or chromatography to ensure intermediate purity
    • Auxiliary recycled within the plant for economic and environmental benefits

    Final product types

    • Sitagliptin intermediates
    • Oseltamivir phosphate intermediates
    • Statin side-chain building blocks
    • Pyrrolidine-based antihypertensive precursors

    2. Enantioselective Diol Protection in Complex Natural Product Synthesis

    Research and production sites engaged in natural product synthesis use this tosyl-protected acetonide as a protective group control reagent for diols and polyols, permitting selective stepwise deprotection and fine-tuning of reactivity across multifunctional molecules. It allows plant chemists to access intermediates with precisely tailored functional group arrays as demanded by total synthesis protocols for semi-synthetic fine chemicals and fermentation product modification.

    Industry compliance standards

    • ISO 9001:2015 for quality management systems in chemical synthesis
    • REACH (EC 1907/2006) Registration for specialty organic chemicals
    • GMP guidelines as per WHO TRS 961, Annex 3 for protected intermediates

    Typical usage ratio

    • 1.0–1.2 equivalents per targeted diol unit; proportion increased in multi-site protection or scale-up for technical batches

    Downstream process integration

    • Added in initial stages after crude extraction to stabilize sensitive diol moieties
    • Reaction run in aprotic solvent, often with base catalysts; temperature maintained 0–40°C
    • Selective deprotection handled in downstream columns before crystallization or further derivatization

    Final product types

    • Semi-synthetic macrolide antibiotics
    • Taxane-type antitumor agent intermediates
    • Polyol-based pheromones and agrochemical actives
    • Synthons for complex carbohydrate modification

    3. Stereoselective Building Block in Chiral Ligand and Catalyst Manufacturing

    Catalyst and ligand producers rely on this intermediate for assembling high-performance chiral ligands applied in asymmetric catalysis for fine chemicals, APIs, and agrochemicals manufacturing. Integration occurs at the ligand scaffold construction stage, providing stereodefined frameworks for transition metal catalysis, especially in cross-coupling and hydrogenation applications. Batch records track configuration and purities to ensure reproducible performance in downstream catalytic steps.

    Industry compliance standards

    • Chemical Manufacturing Safety Standards (OSHA 29 CFR 1910 Subpart Z)
    • ISO 14001:2015 for environmentally sound process control
    • Certificate of Analysis (CoA) per customer specification traceable to ISO/IEC 17025-accredited laboratories

    Typical usage ratio

    • Core fragment: 1.0 equivalent; modifications up to 2.0 equivalents for bidentate/chelating ligand assembly

    Downstream process integration

    • Reacted with aryl or alkyl phosphine precursors or N-donor building blocks
    • Recrystallized for enantiomeric purity in early synthesis phase; direct integration to ligand core assembly
    • Process simulation used to optimize cycle time and YSI (yield, selectivity, input)

    Final product types

    • Numerous BINOL and TADDOL-derived chiral ligands
    • Phosphine-functionalized asymmetric hydrogenation catalysts
    • Diphosphine and P,N-ligand families for industrial homogeneous catalysis
    • C2-symmetric bidentate ligands

    4. Key Intermediate for Stereoselective Synthesis of Advanced Glycosidase Inhibitors

    Producers of glycosidase inhibitors for the pharmaceutical and biotechnology markets utilize this acetonide-protected, bis-tosylated material for the synthesis of highly functionalized intermediates. In these applications, plant chemists perform nucleophilic substitutions and cyclizations with enantiopure control, ensuring the correct stereochemistry required for substrate mimicry in enzyme inhibitory therapies, including rare disease and metabolic syndrome treatments.

    Industry compliance standards

    • GMP guidelines per EudraLex Volume 4 (EU)
    • FDA DMF submission for key intermediates
    • Certificate of Analysis in line with ICH Q6A for specification test methods

    Typical usage ratio

    • 15–35 mol% depending on substitution targets; adjusted based on downstream route, with excess to drive high-yield substitutions at C-1 or C-4 positions

    Downstream process integration

    • Incorporated in the multi-step synthesis after chiral pool derivatization from L-threitol
    • Functionalized via controlled nucleophilic substitution or ring-closure methods
    • Purification via preparative HPLC or crystallization to deliver high-purity intermediates for final API routes

    Final product types

    • Miglitol key intermediates
    • Voglibose intermediates
    • N-alkylated polyhydroxypiperidine building blocks
    • Carbohydrate-mimetic enzyme inhibitor templates
    Free Quote

    Competitive (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol: Selectivity and Reliability for Complex Organic Synthesis

    The Value of High-Purity Chiral Building Blocks

    Formulating advanced intermediates demands more than theoretical know-how and purified analytes. From years of synthesis experience in our plant, consistent success in multi-step chemistry rests on the right choice of chiral building blocks. (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol represents one of those rare cases where utility meets reliability—a product born from repeated trial, lab adaptation, and a persistent push for higher yields across enantioselective transformations.

    Drawn from the structures of C2-symmetric four-carbon sugars, this compound brings clarity and order to asymmetric synthesis. Its structure allows clean introduction of diol motifs while affording exceptional leaving group behavior at the tosyl positions. Time and again, process chemists rely on it to get cleaner separations, faster reactions, and better control over stereochemistry during coupling or further modification steps.

    Manufacturing Approach and Quality Management

    We do not substitute rigorous filtration and monitored distillation when crafting (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol. Batch control means monitoring pressure, temperature, and feed ratios in real time—parameters still easily botched by shortcut chemistry or imprecise instrumentation. On our floor, every step from crude diol formation through tosylation gets tracked for chiral purity by HPLC and documented for spectral identity.

    Ongoing feedback from research partners and production chemists feeds improvements. Decades of hands-on formulation have shown that trace water or residual acid throws off crystallization, so our protocols spot-check for water content below 0.1% and push every lot to exceed 98% chiral purity—sampled as both neat solid and in solution. It costs more in raw labor but cuts headaches from failed scale-up or batch rework. Testing doesn't stop at the drum; random packaging inspection ensures protection in storage and transit, avoiding the risk of clumps or hydrolysis after shipment.

    Specifications Supported by Experience

    Consistently, our in-house preparation delivers (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol as a crystalline solid with particle sizing controlled to minimize dust, allowing easy handling for glovebox work or bulk scale. Melting point routinely sits in the expected range for this diol-diether, and repeated analyses have confirmed the assigned stereochemistry. No parochial or vendor-provided library; we back each lot with NMR, MS, and polarimetry data from our own chemists and raw material tracking that follows every drum from warehouse to reactor.

    The product releases in bulk or research grades. Most frequent requests come for kilogram and multi-kilogram orders. We support smaller scales for early synthesis or analytical method development. Our experience shows maintaining the same grade for both R&D and production stops process drift and avoids headaches scaling reactions from gram to multi-kilogram levels.

    Key Distinctions from Other Tosylated Diols and Related Intermediates

    Any diol can carry tosyl groups, but years synthesizing C2-symmetric intermediates exposed key differences. The (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol structure locks carbons 2 and 3 with an isopropylidene acetal. This sacrifices flexibility, but gains predictable reactivity. In practice, that acetal means lower reactivity towards unwanted side hydrolysis, so batch reproducibility stands up through humid summers and inconsistent warehouse climates.

    Other tosylated four-carbon diols, particularly those lacking the acetonide, show frequent migration of tosyl or even elimination under mild conditions. Customers often report scrambled products in recycling batch reactors or loss of yield after cycling crude mother liquors. With our specific acetal-protected format, these headaches do not arise—yield loss from migration or scrambling turns negligible, and the labor of requalification disappears.

    For enantioselective applications, the (-)-enantiomer stabilizes downstream intermediates, supporting catalyst design where small differences in building block purity appear big in final product resolution. Many users in pharmaceutical R&D highlight easier chiral pool synthesis using this backbone, especially for relatively unstable heterocyclic or macrocyclic cores. Synthetic flexibility drops if the isopropylidene is not present since direct manipulation of unprotected diols proves less selective and much less efficient in late-stage functionalization.

    Applications from Decades of Direct Use

    Products like (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol become essential in peptide scaffold assembly and synthesis of natural product-like molecules. Our colleagues in the field point to several convergent synthesis routes where the stereocontrol at both diol carbons lets them streamline construction of macrocycles, nucleoside analogs, and spirocyclic intermediates—reducing protection/deprotection cycles, and keeping solvent use down.

    Process engineers with tight regulatory timelines turn to this product to accelerate routes that might otherwise bog down at purification or diastereomer separation steps. Documented cases show better recovery of final products just by switching starting materials from less robust chiral diols or byproducts-laden reagents to our consistently manufactured tosyl derivative. Bench chemists save time on TLC and HPLC cleanup because predictable reaction progress makes scale-up safer and solveable. Our plant technical support spends less time troubleshooting failed couplings and more on improving throughput for downstream products.

    Handling and Storage Learned the Hard Way

    It doesn’t take long in a process plant to appreciate how improper storage degrades sensitive intermediates. With experience, we moved from open bins to moisture-proof sealed packaging using double-laminated bags and tightly sealed containers. The acetal on (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol holds strong during transport, but we still run routine checks on incoming and outgoing lots for water uptake.

    Days working in synthesis lines taught us the cost of losing material to caking, off-odors, or color change. Long before this became expected by external audits, we established a quality chain ensuring batches remain bright, crystalline, and free-flowing from filling to delivery. Shipping rarely poses issues with this product, but we guide every user on best storage including chilling where large-scale lots see heat during transfer.

    Most chemical plants fear product recalls due to reactivity changes over storage; years supplying this tosylate have demonstrated that acetal stabilization makes a practical difference under real-world conditions. Our records show complaint and requalification rates far lower than with other diol derivatives, easing burden for QA labs downstream.

    Supporting Complex Synthesis—A Tool for Innovation

    One recurring lesson from collaborating with synthetic chemists across pharma and materials labs: their most advanced molecules often fail for reasons traceable to one intermediate. Many find (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol delivers an edge where cost of late-stage process failures risks deadlines or IP loss. Its use grew as process development projects attempted higher yields, lower impurity profiles, and stricter stereochemical control.

    Specialty catalysis also benefits. Chemists investigating new ligand scaffolds for metal complexes rely on rigid, well-defined chiral building blocks. The structure here brings desirable rigidity—giving sharper NMR signals in complex mixtures, which benefits fast screening and troubleshooting. Transition metal-catalyzed cross-couplings, in particular, exhibit better selectivity with this intermediate due to consistent geometry and less ligand scrambling.

    Our internal R&D chemists track how altering the diol acetal structure or substituting alkylidene groups impacts downstream product purity. Through iterative synthesis and direct feedback from in-plant runs, we keep refining protocols to increase output and lower impurity carryover to successive steps. Customers have reported up to 20% improved yields just by switching from less stable analogs.

    Environmental and Safety Factors Integrated into Production

    Years in large-scale synthesis reveal the environmental impacts of unoptimized batch processes. The advantage with this derivative over more sensitive or volatile analogs ties back to predictable reactivity. Waste generation drops because hydrolytic loss diminishes with the acetal in place—so less acid or base is required downstream for neutralization steps. The overall carbon footprint also improves because reaction temperatures remain moderate, limiting the need for energy-intensive cooling or heating.

    From the safety side, the relatively stable solid form means fewer concerns about accidental spills or vapor emissions compared to lower-mass, oil-soluble intermediates. In our facility, operators report easier weighing and transfer, and compliance audits consistently mark lower incident rates for this product than for more fragile reagents.

    Waste management plans target minimal process solvent residuals, and in years of plant operation, recovery rates from mother liquors average above 95%. Proper handling and experienced plant management minimize employee risk and environmental exposure, supporting both process efficiency and responsible stewardship.

    Supporting Documentation and Traceability

    Within our manufacturing chain, traceability goes deeper than a simple batch log. Each shipment draws from master production records documenting instrument calibrations, raw material checks, and in-process controls—vital for meeting the demands of regulated industries. Our systems document each change of raw material supplier and packaging shift, so downstream partners avoid surprises during validation.

    Certifications supporting chiral purity, spectral match, and identity remain on file for every lot. Years working under regulatory frameworks drove us to develop archiving and sampling regimens exceeding industry minimums. Recalls or field re-testing remain rare; customers trust our site-specific controls and transparency, which reduces uncertainty during audits and technical transfer.

    Feedback cycles involve direct conversations with plant managers or process scientists so changes in specification actually reflect on-the-ground needs. This approach lets us continuously align our output with what real-world chemistry projects require for both internal and external partners.

    Lessons from Field Use and Ongoing Development

    No single intermediate solves all production problems; experienced hands know that process optimization never stops. Yet, market feedback and our own troubleshooting point to (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol as a backbone of efficient synthesis—particularly where high-value pharmaceutical or specialty chemical targets require robust, predictable, and selective groundwork.

    We encourage technical feedback directly from users, embracing both criticism and suggestions for improvement. Often, modifications to grain size, packaging, or handling instructions arise from practical user problems, not just theoretical optimization. For example, we have adjusted crystallization solvents and drum closures based on field advice and supply changes in raw materials, a practice grown out of long-term collaboration rather than short-term salesmanship.

    By integrating continuous improvement, scientific validation, and close support for users, our experience with (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol highlights how well-made specialty intermediates move from lab curiosity to backbone of industrial synthesis.

    Practical Solutions and Community Collaboration

    Manufacturing isn’t just about making a chemical; it’s about anticipating challenges for production, scale-up, and innovation. Real-world chemistry has taught us that consistency in critical intermediates pays for itself: lower rates of rework, higher product quality, and smoother audits. Whether supporting contract manufacturing partners, global R&D teams, or internal process scale-up, the proof lies in reliable performance.

    We don’t claim to know every challenge a customer might face, but years supplying advanced chiral intermediates like (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol sharpen our focus on process safety, product stability, and technical transparency. These priorities, forged in practice and not just protocol, drive us to keep refining our offering and learning from the community we serve.